A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

The once-extinct dire wolf species has been brought back to life after 10,000 years, and George R.R. Martin ‘s “ Game of ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into Vita's cell therapeutic programs. This nonexclusive ...

Colossal Biosciences—the company whose mission is “de-extinction”—has pulled off one of the wildest feats in modern science: ...

The next generation of genetically altered food is forging ahead, aiming to be attractive to consumers rather than producers.

The FDA granted Crispr Therapeutics (CRSP) orphan status for its treatment of follicular lymphoma.Don't Miss Our End of Quarter Offers: ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

DELRAY BEACH, Fla., March 31, 2025 /PRNewswire/ -- The plant breeding and CRISPR plants market is estimated at USD 8.91 billion in 2025 and is projected to reach USD 13.86 billion by 2030, at a CAGR ...